Abstract
Treatment of nine boys, aged 2.8–16.3 years, with growth retardation consequent to chronic renal failure (CRF), with recombinant human growth hormone (rhGH) for 12–36 months demonstrated a significant improvement in growth velocity at each 12-month interval compared with that achieved the year prior to treatment. Despite the acceleration in growth velocity the bone age did not increase more than the increase in chronological age during the period of treatment. The mean calculated creatinine clearance did not decrease significantly during the 36 months of treatment; however, two patients required institution of dialysis at 18 and 30 months following the initiation of rhGH treatment. There was no exacerbation of the glucose intolerance of uremia following rhGH treatment. Currently, six of seven patients who have been treated for more than 24 months have achieved sufficient acceleration of growth velocity to attain a standard deviation score that was more positive than −2.00, and are above the 5th per centile for chronological age on the growth curve. These data indicate that rhGH treatment of growthretarded children with CRF results in accelerated growth velocity during the 2nd and 3rd years of treatment, and demonstrate the potential for such children to achieve normal stature for chronological age despite the continued presence of renal failure.
Similar content being viewed by others
References
Mehls O, Ritz E (1983) Skeletal growth in experimental uremia. Kidney Int [Suppl 15]: S53-S60
Mehls O, Ritz E, Hunziker EE, Eggli P, Heinrich U, Zapf J (1988) Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 33: 45–52
Powell DR, Rosenfeld RG, Hintz RL (1988) Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure. Pediatr Nephrol 2: 425–430
Nakano M, Kainer G, Foreman JW, Ko D, Chan JCM (1989) The effects of exogenous rat growth hormone therapy on growth of uremic rats fed an 8% protein diet. Pediatr Res 26: 204–207
Lippe BM, Fine RN, Koch VH, Sherman BM (1988) Accelerated growth following recombinant human growth hormone (rhGH) in children with chronic renal failure. Acta Paediatr Scand [Suppl] 343: S127-S131
Koch VH, Lippe BM, Nelson PA, boechat MI, Sherman BM, Fine RN (1989) Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr 115: 365–371
Fine RN, Koch VH, Nelson PA, Boechat MI, Fine SE, Sherman BM, Lippe BH (1990) Recombinant human growth hormone (rhGH) treatment of children with renal insufficiency. Adv Nephrol 19: 187–208
Schwartz GJ, Haycock MB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263
Fass B, Lippe BM, Kaplan SA (1979) Relative usefulness of three growth hormone stimulating tests. Am J Dis Child 133: 931–933
Powell DR, Rosenfeld RG, Sperry JB, Baker BK, Hintz RL (1987) Serum concentrations of insulin-like growth factors (IGF-1), IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 4: 287–292
Foreman JM, Kainer G, Nakano M, Boyle F, Chan JCM (1989) Severe hypercalciuria: an unexpected result of concurrent use of 1,25-dihydroxyvitamin D3 and growth hormone in uremic rats. Pediatr Nephrol 3: C205
Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford
Roche AF (1978) Growth assessment in abnormal children. Kidney Int 14: 369–377
Tonshoff B, Mehls O, Schauer A, Heinrich U, Blum W, Ranke M (1989) Improvement of uremic growth failure by recombinant human growth hormone. Kidney Int 36 [Suppl 27]: S201-S204
Wilson DP, Jelley D, Stratton R, Coldwell JG (1989) Nephropathic cysytinosis: improved linear growth after treatment with recombinant human growth hormone. J Pediatr 115: 758–761
Christiansen SJ, Gammelgaard J, Orskov H, Andersen AR, Telmer S, Parving HH (1981) Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 11: 487–490
Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and progressive nature of kidney disease. N Engl J Med 307: 652–659
Haffner D, Zacharewicz S, Mehls O, Heinrich U, Ritz E (1989) The acute effect of growth hormone on GFR is obliterated in chronic renal failure. Clin Nephrol 32: 266–269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fine, R.N., Pyke-Grimm, K., Nelson, P.A. et al. Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome. Pediatr Nephrol 5, 477–481 (1991). https://doi.org/10.1007/BF01453685
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01453685